EP 1242050 A2 20020925 - SURVIVIN PROMOTION OF ANGIOGENESIS
Title (en)
SURVIVIN PROMOTION OF ANGIOGENESIS
Title (de)
FÖRDERUNG DER ANGIOGENESE DURCH SURVIVIN
Title (fr)
STIMULATION DE L'ANGIOGEN SE PAR L'UTILISATION DE SURVIVINE
Publication
Application
Priority
- US 0034663 W 20001221
- US 17299199 P 19991221
Abstract (en)
[origin: WO0146455A2] The present invention discloses methods for promoting angiogenesis using agents that increase the activity function and/or expression of survivin. The present invention also discloses methods for inhibiting angiogenesis using agents that inhibit activity, the function and/or expression of survivin.
IPC 1-7
C07K 14/47; C07K 14/515; C12N 15/12; A61K 31/711; A61K 31/713; A61K 38/17; A61K 48/00
IPC 8 full level
A61K 31/7088 (2006.01); A61K 35/12 (2006.01); A61K 35/76 (2006.01); A61K 38/22 (2006.01); A61K 38/48 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61L 31/00 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 43/00 (2006.01); C07K 14/47 (2006.01); C07K 14/515 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01)
CPC (source: EP)
A61P 9/00 (2017.12); A61P 9/10 (2017.12); A61P 43/00 (2017.12); C07K 14/4747 (2013.01); C07K 14/515 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0146455 A2 20010628; WO 0146455 A3 20020510; AU 2730801 A 20010703; CA 2393646 A1 20010628; EP 1242050 A2 20020925; EP 1242050 A4 20040526; JP 2003529554 A 20031007; MX PA02006167 A 20040226
DOCDB simple family (application)
US 0034663 W 20001221; AU 2730801 A 20001221; CA 2393646 A 20001221; EP 00990262 A 20001221; JP 2001546951 A 20001221; MX PA02006167 A 20001221